Head
office
Headquarters in the UK, with Operations based in the U.S.
United Kingdom:
GlaxoSmithKline,
Glaxo Wellcome UK Ltd.,
Stockley Park West,
Uxbridge,
Middlesex, UB11 1BT
General Enquiries:
Tel: +44 (0)20 8990 9000
Fax: +44 (0)20 8990 4321
United States:
GlaxoSmithKline
5 Moore Drive
P.O. Box 13398
Research Triangle Park
NC 27709
Phone: +1 888 825 5249
Company Structure/Ownership
GlaxoSmithKline plc is a publicly owned company.
Board of Directors
[11]
Sir Christopher Hogg, Chairman
Sir Hogg was appointed to the Board of SmithKline Beecham as a
Non-executive Director in 1993. He is Non-executive Chairman of Reuters
Group PLC and Allied Domecq PLC, and a Non-executive Director of Air
Liquide S.A.
J.P. Garnier, Chief Executive Officer
Mr. Garnier became CEO of GSK in 2000. In August 2001 he was listed
in the Guardian among the top ten highest paid CEOs, earning £2.5
million per year (including options and bonuses). [12] He also contributes
to the ‘quality of human life’ by sitting on the board of
arms manufacturer United Technologies, the maker of the Blackhawk
helicopter and other warplanes. [13]
John Coome, Chief Financial Officer
Mr Coombe joined Glaxo Holdings as Group Financial Controller
in 1986 and was appointed to the Board in July 1992. His other business
appointments include membership of the Accounting Standards Board,
Deputy Chairman of The Hundred Group of Finance Directors and a member
of the Code Committee of the Takeover Panel.
Paul Allaire, Chairman of Remuneration and Nominations
Committee
Born on 21st July 1938, Paul Allaire was appointed to the Board
of SmithKline Beecham as a Non-Executive Director in 1993. He is also
Chairman of Xerox Corporation and a Non-executive Director of JP Morgan
& Co. Inc, Lucent Technologies Inc, Sara Lee Corporation and Priceline.com
Inc. Food giant Sara Lee is regularly criticised for selling unhealthy
food. While Glaxo’s ‘mission statement’ includes ‘enabling
people to do more, feel better and live longer’ Sara Lee pleaded
guilty in June 2001 to selling bad meat that killed 15 people and
caused six miscarriages. He is also on the Board of Trustee of Carnegie
Mellon University.[14]
Dr. Michele Barzach, Non-Executive Director
Appointed as a Non-executive Director of Glaxo Wellcome in 1997.
Dr. Barzach also works for the World Bank as Chairman of the External
Advisory Panel for Health, Nutrition and Population. She was formerly
French Minister of Health and the Family.[15]
Sir Roger Hurm, Non-Executive Deputy Chairman
Born 9th June 1938, Sir Roger was appointed non-executive Director
of Glaxo Wellcome plc in 1996 and Deputy Chairman in 1997. He was
also Chairman of Marconi (formerly GEC) until he was forced to resign
in September 2001 due to the companies collapsing share prices. He
is a Non-executive Director of ICI plc. ICI was number one in the
Environment Agency’s 1999 ‘hall of shame’ league table
of polluters.[16]
Sir Peter Job, Non-Executive Director
Sir Peter Job is a Non-executive Director of GlaxoSmithKline.
He was appointed as a Non-executive Director of Glaxo Wellcome in
1997 and is a Non-executive Director of Schroders plc. Sir Peter was
awarded a Knight of the British Empire (KBE) by the queen. The honour
was received for services to the information and media industry.[17]
John McArthur, Non-Executive Director
He was appointed as a Non-executive Director of Glaxo Wellcome
in 1996. He is a former Dean of the Harvard Business School, and is
a Director of BCE Inc., Cabot Corporation, Rohm and Haas Company,
Springs Industries Inc. and The AES Corporation.[18]
Donald McHenry, Non-Executive Director
Born on 13th October 1936, Donald McHenry was appointed to the
Board of SmithKline Beecham as a Non-executive Director in 1989. He
is a Non-executive director of the Coca-Cola Company, which has been
criticised for its labour and environmental practices and the aggressive
marketing of its high-sugar drinks. Other Non-executive Directorships
include FleetBoston Financial Corporation and AT&T Corporation
. He previously served as Ambassador and US Permanent Representative
to the United Nations. [19]
Sir Ian Prosser, Non-Executive Director
Born 5th July 1943, Ian Prosser was appointed to the Board of
SmithKline Beecham as a Non-executive Director in 1999. He is Executive
Chairman of the pub owner Bass PLC. In addition he non-executive Deputy
Chairman of BP Amoco plc, a company criticised for its pollution record
He is also a member of the CBI President's Committee, an industry
lobby group.[20]
Dr. Ronaldo Schmitz, Chairman of Audit Committee
Mr. Schmitz was appointed as a Non-executive Director of Glaxo
Wellcome in 1997. He is also a former member of the Board of Managing
Directors of Deutsche Bank AG and a member of the Supervisory Board
of Bertelsmann AG and the Board of Directors of Rohm and Haas Company.[21]
Dr. Lucy Shapiro, Non-Executive Director
Dr. Shapiro was appointed to the Board of SmithKline Beecham as
a Non-executive Director in 1996. She is Professor in the Department
of Developmental Biology and Director of the Beckman Center at the
Stanford University School of Medicine.[22]
Turnover
In 2001, GlaxoSmithKline had sales totalling £20.5 billion,
and before tax profits of £6.2 billion.[23]
Number
of Employees
GSK employs 100,000 people, 40,000 of which work in Sales and Marketing.[24]
